Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria

Asim, Allerji, Immunoloji - Turkey
doi 10.21911/aai.413
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Turkish National Society of Allergy and Clinical Immunology

Related search

Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria

Bőrgyógyászati és Venerológiai Szemle
2015English

The Efficacy of Omalizumab Therapy in Chronic Spontaneous Urticaria: A Retrospective Analysis

Turkderm Deri Hastaliklari ve Frengi Arsivi
DermatologyInfectious Diseases
2019English

Transient Hair Loss in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2017English

Omalizumab in Chronic Urticaria: A Comprehensive Review

Turkderm Deri Hastaliklari ve Frengi Arsivi
DermatologyInfectious Diseases
2018English

Clinical Management of Urticaria Using Omalizumab: The First Licensed Biological Therapy Available for Chronic Spontaneous Urticaria

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2016English

Omalizumab Updosing Allows Disease Activity Control in Refractory Patients With Chronic Spontaneous Urticaria

British Journal of Dermatology
DermatologyMedicine
2018English

Serum Autoreactivity Predicts Time to Response to Omalizumab Therapy in Chronic Spontaneous Urticaria

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency

Frontiers in Immunology
AllergyImmunology
2019English

Cost of Treatment of Chronic Spontaneous Urticaria in Turkey

Health
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy